Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Production of Trimeric SARS-CoV-2 Spike Protein by CHO Cells for Serological COVID-19 Testing

Yusuf B. Johari, Stephen R.P. Jaffé, Joseph M. Scarrott, Abayomi O. Johnson, Théo Mozzanino, Thilo H. Pohle, Sheetal Maisuria, Amina Bhayat-Cammack, Adam J. Brown, Kang Lan Tee, Philip J. Jackson, Tuck Seng Wong, Mark J. Dickman, Ravishankar Sargur, David C. James
doi: https://doi.org/10.1101/2020.08.07.20169441
Yusuf B. Johari
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen R.P. Jaffé
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph M. Scarrott
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abayomi O. Johnson
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Théo Mozzanino
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thilo H. Pohle
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheetal Maisuria
2Department of Immunology, Sheffield Teaching Hospitals NHS Foundation Trust, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amina Bhayat-Cammack
2Department of Immunology, Sheffield Teaching Hospitals NHS Foundation Trust, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J. Brown
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kang Lan Tee
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip J. Jackson
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuck Seng Wong
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Dickman
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravishankar Sargur
2Department of Immunology, Sheffield Teaching Hospitals NHS Foundation Trust, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. James
1Department of Chemical and Biological Engineering, University of Sheffield, Mappin St., Sheffield S1 3JD, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: d.c.james{at}sheffield.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

We describe scalable and cost-efficient production of full length, His-tagged SARS-CoV-2 spike glycoprotein trimer by CHO cells that can be used to detect SARS-CoV-2 antibodies in patient sera at high specificity and sensitivity. Transient production of spike in both HEK and CHO cells mediated by PEI was increased significantly (up to 10.9-fold) by a reduction in culture temperature to 32°C to permit extended duration cultures. Based on these data GS-CHO pools stably producing spike trimer under the control of a strong synthetic promoter were cultured in hypothermic conditions with combinations of bioactive small molecules to increase yield of purified spike product 4.9-fold to 53 mg/L. Purification of recombinant spike by Nichelate affinity chromatography initially yielded a variety of co-eluting protein impurities identified as host cell derived by mass spectrometry, which were separated from spike trimer using a modified imidazole gradient elution. Purified CHO spike trimer antigen was used in ELISA format to detect IgG antibodies against SARS-CoV-2 in sera from patient cohorts previously tested for viral infection by PCR, including those who had displayed COVID-19 symptoms. The antibody assay, validated to ISO 15189 Medical Laboratories standards, exhibited a specificity of 100% and sensitivity of 92.3%. Our data show that CHO cells are a suitable host for the production of larger quantities of recombinant SARS-CoV-2 trimer which can be used as antigen for mass serological testing.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Sheffield Teaching Hospitals NHS Foundation Trust, UK.

MJD acknowledges support from the Biotechnology and Biological Sciences

Research Council UK (BBSRC) (BB/M012166/1)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Local R&D and ethics committees advised ethics approval was not required. The interpretation was this is governed under the Development, validation and verification of new assays and the UKAS Laboratory accreditation quality governance framework. The name of the entity is Sheffield Teaching Hospital Research and Innovation Office.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data discussed in the text is submitted as supplementary information.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 13, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Production of Trimeric SARS-CoV-2 Spike Protein by CHO Cells for Serological COVID-19 Testing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Production of Trimeric SARS-CoV-2 Spike Protein by CHO Cells for Serological COVID-19 Testing
Yusuf B. Johari, Stephen R.P. Jaffé, Joseph M. Scarrott, Abayomi O. Johnson, Théo Mozzanino, Thilo H. Pohle, Sheetal Maisuria, Amina Bhayat-Cammack, Adam J. Brown, Kang Lan Tee, Philip J. Jackson, Tuck Seng Wong, Mark J. Dickman, Ravishankar Sargur, David C. James
medRxiv 2020.08.07.20169441; doi: https://doi.org/10.1101/2020.08.07.20169441
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Production of Trimeric SARS-CoV-2 Spike Protein by CHO Cells for Serological COVID-19 Testing
Yusuf B. Johari, Stephen R.P. Jaffé, Joseph M. Scarrott, Abayomi O. Johnson, Théo Mozzanino, Thilo H. Pohle, Sheetal Maisuria, Amina Bhayat-Cammack, Adam J. Brown, Kang Lan Tee, Philip J. Jackson, Tuck Seng Wong, Mark J. Dickman, Ravishankar Sargur, David C. James
medRxiv 2020.08.07.20169441; doi: https://doi.org/10.1101/2020.08.07.20169441

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)